BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30904414)

  • 21. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.
    Dorman S; Byrne A; Edwards A
    Palliat Med; 2007 Apr; 21(3):177-91. PubMed ID: 17363394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.
    Currow DC; Smith J; Davidson PM; Newton PJ; Agar MR; Abernethy AP
    J Pain Symptom Manage; 2010 Apr; 39(4):680-90. PubMed ID: 20413056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the Appropriate Washout Period Following Fan Therapy for Dyspnea in Patients With Advanced Cancer: A Pilot Study.
    Kako J; Morita T; Yamaguchi T; Sekimoto A; Kobayashi M; Kinoshita H; Ogawa A; Zenda S; Uchitomi Y; Inoguchi H; Matsushima E
    Am J Hosp Palliat Care; 2018 Feb; 35(2):293-296. PubMed ID: 28468508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of refractory dyspnoea in patients with advanced diseases - evidence-based update for clinical practice].
    Simon ST; Altfelder N; Voltz R; Gaertner J
    Ther Umsch; 2012 Feb; 69(2):93-7. PubMed ID: 22334199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy.
    Booth S; Moosavi SH; Higginson IJ
    Nat Clin Pract Oncol; 2008 Feb; 5(2):90-100. PubMed ID: 18235441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetoencephalography to investigate central perception of exercise-induced breathlessness in people with chronic lung disease: a feasibility pilot.
    Johnson MJ; Simpson MI; Currow DC; Millman RE; Hart SP; Green G
    BMJ Open; 2015 Jun; 5(6):e007535. PubMed ID: 26063567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
    Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
    J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report.
    Farquhar M; Higginson IJ; Fagan P; Booth S
    Palliat Support Care; 2010 Jun; 8(2):143-9. PubMed ID: 20307365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on combined modalities for the management of breathlessness.
    Clemens KE; Faust M; Bruera E
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):163-7. PubMed ID: 22469671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of acute breathlessness in the person with chronic refractory breathlessness.
    Donesky D
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):212-6. PubMed ID: 26147913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of resistance inspiratory muscle training in the management of breathlessness in patients with thoracic malignancies: a feasibility randomised trial.
    Molassiotis A; Charalambous A; Taylor P; Stamataki Z; Summers Y
    Support Care Cancer; 2015 Jun; 23(6):1637-45. PubMed ID: 25417042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of refractory breathlessness with morphine in patients with chronic obstructive pulmonary disease.
    Smallwood N; Le B; Currow D; Irving L; Philip J
    Intern Med J; 2015 Sep; 45(9):898-904. PubMed ID: 26332621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does palliative home oxygen improve dyspnoea? A consecutive cohort study.
    Currow DC; Agar M; Smith J; Abernethy AP
    Palliat Med; 2009 Jun; 23(4):309-16. PubMed ID: 19304806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive Behavioral Therapy for Management of Dyspnea: A Pilot Study.
    Williams MT; Cafarella P; Paquet C; Frith P
    Respir Care; 2015 Sep; 60(9):1303-13. PubMed ID: 25969515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome measurement of refractory breathlessness: endpoints and important differences.
    Ekström M; Currow DC; Johnson MJ
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):238-43. PubMed ID: 26203849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breathlessness in advanced disease. 1: Definitions, epidemiology and pathophysiology.
    Barnes D
    Nurs Times; 2010 Nov 2-8; 106(43):20-1. PubMed ID: 21155499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaps in the evidence base of opioids for refractory breathlessness. A future work plan?
    Johnson MJ; Abernethy AP; Currow DC
    J Pain Symptom Manage; 2012 Mar; 43(3):614-24. PubMed ID: 22285285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosocial consequences of living with breathlessness due to advanced disease.
    Janssen DJ; Wouters EF; Spruit MA
    Curr Opin Support Palliat Care; 2015 Sep; 9(3):232-7. PubMed ID: 26125305
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a breathlessness assessment guide for use in palliative care.
    Corner J; O'Driscoll M
    Palliat Med; 1999 Sep; 13(5):375-84. PubMed ID: 10659109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup.
    Dorman S; Jolley C; Abernethy A; Currow D; Johnson M; Farquhar M; Griffiths G; Peel T; Moosavi S; Byrne A; Wilcock A; Alloway L; Bausewein C; Higginson I; Booth S
    Palliat Med; 2009 Apr; 23(3):213-27. PubMed ID: 19251835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.